GTHX(Delisted)
G1 TherapeuticsยทNASDAQ
--
--(--)
GTHX fundamentals
G1 Therapeutics (GTHX) released its earnings on Feb 21, 2018: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
Feb 21, 2018
EPS
Revenue
Revenue & Expenses
GTHX has released its 2024 Q2 earnings report, with revenue of 16.55M, reflecting a YoY change of -60.97%, and net profit of -5.47M, showing a YoY change of -162.79%. The Sankey diagram below clearly presents GTHX's revenue sources and cost distribution.
Key Indicators
G1 Therapeutics (GTHX) key financial stats and ratios, covering profitability, financial health, and leverage.
G1 Therapeutics (GTHX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
G1 Therapeutics (GTHX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
G1 Therapeutics (GTHX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does G1 Therapeutics (GTHX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track G1 Therapeutics (GTHX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
